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INTRODUCTION
Bacterial meningitis remains as an important clinical prob-
lem at any age, and is accompanied by significantly high mor-
tality and morbidity despite the development of highly active
new antibiotics and intensive care medicine. The prognosis
is particularly poor in neonates with mortality rates of 20-
40% and long-term neurologic sequelae in up to 50% of sur-
vivors (1-3). Therefore, better understanding of the patho-
physiology of neonatal bacterial meningitis would be neces-
sary to develop new adjuvant therapies that can improve the
outcome of this disease. 
Excitatory amino acids (EAA) are increasingly implicated
in the pathogenesis of neuronal injury induced by a variety
of central nervous system insults, such as ischemia, trauma,
hypoglycemia and epilepsy (4-7). Glutamate is the most ab-
undant excitatory amino acid neurotransmitter in human,
being stored in presynaptic vesicles and released in response
to presynaptic neuronal membrane depolarization, and the
N-methyl-D-aspartate (NMDA) subtype of glutamate recep-
tor is considered to play a pivotal role in enabling glutamate
to express its neurotoxic potential in a variety of neurologi-
cal disorders. Binding of glutamate to specific NMDA recep-
tors opens transmembrane ion channels, with a subsequent
excessive increase in intracellular sodium, calcium, and water,
which elicits an initial swelling of the cells and delayed cas-
cade of enzyme activation, finally leading to cell death (8).
The immature brain is particularly vulnerable to the effects
of glutamate release due to greater density and proportion of
the NMDA receptor sites compared to the adult brain (9). 
Elevated concentrations of excitotoxic amino acids in the
cerebrospinal fluid (CSF) and brain interstitial fluid have also
been reported in both experimental (10, 11) and clinical stud-
ies of bacterial meningitis (8), and the administration of glu-
tamate receptor antagonist kynurenic acid attenuated the neu-
ronal injury in experimental bacterial meningitis (12). These
findings suggest that excitotoxicity may mediate the neuronal
injury and that NMDA antagonist may be an attractive new
adjuvant therapeutic agent to attenuate the acute inflamma-
tory responses and to ameliorate neuronal injury in neonatal
bacterial meningitis. 
In the present study, we evaluated the efficacy of noncom-
petitive NMDA antagonist MK-801 (dizocilpine) as an adju-
vant therapy in attenuating the acute inflammatory respons-
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Effects of MK-801 (dizocilpine) on Brain Cell Membrane Function 
and Energy Metabolism in Experimental Escherichia coli Meningitis 
in the Newborn Piglet
We evaluated the efficacy of non-competitive N-methyl-D-aspartate receptor
antagonist MK-801 (dizocilpine) as an adjuvant therapy in experimental neonal
bacterial meningitis. Meningitis was induced by injecting 10
6 colony forming units
of Escherichia coli into the cisterna magna. MK-801 3 mg/kg was given as a bolus
intravenous injection, 30 min before the  induction of meningitis. MK-801 did not
down-modulate the inflammatory parameters, such as increased intracranial pres-
sure, cerebrospinal fluid (CSF) leukocytosis, increased lactate and TNF- levels
in the CSF, and hypoglycorrhachia observed in the meningitis group. MK-801
did not significantly attenuate the elevated glutamate concentration in the CSF.
However, MK-801 showed some neuroprotective effects as evidenced by signif-
icant attenuation of cerebral lipid peroxidation products (conjugated dienes) and
increase of brain high-energy phosphate compounds (ATP and PCr). Improve-
ment in cerebral cortical cell membrane Na
+, K
+-ATPase activity did not reach a
statistical significance. These results suggest that MK-801 was effective in ame-
liorating brain injury in neonatal bacterial meningitis, although it failed to attenu-
ate the inflammatory responses. 
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es and ameliorating brain damage in neonatal bacterial me-
ningitis. We tested the hypothesis that MK-801 attenuates the
acute inflammatory responses and ameliorates the develop-
ment of brain injury in experimental Escherichia coli menin-
gitis in the newborn piglet. In this study, we used the new-
born piglet as an animal model of neonatal bacterial menin-
gitis because the piglet brain is comparable to human brain
at birth in growth velocity, energy metabolism and vascular
anatomy (13, 14). E. coli was used to induce meningitis be-
cause it is the most common Gram-negative pathogen of
neonatal bacterial meningitis (1). Inflammatory responses
were assessed by monitoring changes in intracranial pressure
(ICP), tumor necrosis factor-alpha (TNF- ) level, glucose and
lactate concentrations, and leukocyte counts in the CSF. Menin-
gitis-induced alterations in brain cell membrane structure,
function, and energy stores were determined by measuring
lipid peroxidation products (conjugated dienes), Na
+, K
+-
ATPase activity, and concentrations of high-energy phos-
phate compounds (ATP and phosphocreatine) in the cere-
bral cortex, respectively. 
MATERIALS AND METHODS
Animal preparation
The experiments described herein were reviewed and appr-
oved by the Institutional Animal Care and Use Committee
of the Samsung Biomedical Research Center, Seoul, Korea.
This study followed the institutional and National Institutes
of Health guidelines for laboratory animal care.  
Newborn piglets of mixed strain (Yorkshire, conventional
breed purchased from Paju farm, Paju, Kyunggi-Do, Korea)
less than 3 days were used in this study. Animals were inhaled
with ether for sedation and anesthesia was induced with sodi-
um thiopental 5 mg/kg intravenously and supplemental doses
were given as required to maintain anesthesia. After local in-
jection with lidocaine (1%), tracheostomy was performed
and the piglet was paralyzed with pancuronium 0.1 mg/kg
intravenously and ventilated with neonatal pressure limited-
time cycled mechanical ventilator (Sechrist Infant Ventilator,
IV-100B, Sechrist Industries Co., Anaheim, CA, U.S.A.). Ven-
tilator settings were adjusted to keep arterial PO2 at 80-100
mmHg, and PCO2 at 35-45 mmHg. Femoral arteries and
veins were cannulated for blood pressure monitoring, blood
sampling, and for medication and fluid infusion, respective-
ly. Heart rate, ECG, oxygen saturation, ICP and blood pres-
sure were continuously monitored using Hewlett Packard
neonatal monitoring system (Hewlett Packard Model M12-
76A, Hewlett Packard Co., MA, U.S.A.). Cisternal punc-
ture was done with a 22 gauge spinal needle (Becton Dick-
inson, Franklin Lakes, NJ, U.S.A.) and the needle was kept
in situ for continuous ICP monitoring and intermittent CSF
sampling. Throughout the experiment the piglet was placed
under the servo-controlled warmer (Airshields Inc., Hatboro,
PA, U.S.A.) and rectal temperature was maintained between
38.0 and 39.0℃.
Bacterial preparation
E. coli strain used in this study was EC69 strain (gift of Dr.
Kwang Sik Kim, University of Southern California, Los Ange-
les, Calif., U.S.A.). EC69 strain was generated by P1 transduc-
tion of the E. coli K12 outer membrane protein A (Omp A)
gene to Omp A-mutant of RS218, a CSF isolate from a new-
born with E. coli meningitis (15). The organism was cultured
overnight in 10 mL of brain heart infusion broth (BHI, Difco
Laboratories, Detroit, Mich., U.S.A.), diluted in fresh medi-
um, and grown for 1 hr to mild-logarithmic phase. 
The suspension was centrifuged for 10 min at 5,000 g and
resuspended in normal saline, and the absorbance was mea-
sured to adjust the bacterial density to the desired concentra-
tion.
Experimental protocol
After the surgery and stabilization period, 44 newborn pig-
lets were randomly divided into three groups; 9 in the normal
control group (NC), 21 in the meningitis control group (MC),
and 14 in the meningitis with MK-801 treatment group
(MK). Meningitis was induced by injection of 108 colony for-
ming units (CFU) of E. coli in 100  Lof saline into the cister-
na magna. In MK, 3 mg/kg of MK-801 (Sigma, St. Louis,
Mo., U.S.A.) in distilled water was given as a bolus intravenous
injection 30 min before intracisternal bacterial inoculation.
Heart rate, ECG, ICP, blood pressure, and oxygen saturation
were continuously monitored during the experiment.  
Arterial blood gas analyses, glucose, lactate concentra-
tions in the blood and CSF were measured at baseline and
every hour for 4 hr after the bacterial inoculation. Bacterial
titers in the CSF were measured by plating 10-fold dilu-
tions on blood agar plates overnight at 37℃ in room air.
CSF leukocyte counts were measured using hemocytometer,
and TNF- concentrations were measured with commer-
cially available ELISA kit for human TNF- (Predicta
�, Gen-
zyme, Cambridge, Mass., U.S.A.). Arterial blood gases were
measured on a blood gas analyzer (Ciba-Corning Diagnos-
tics Corp., Medfield, MA, U.S.A.) and concentrations of
glucose and lactate were measured using a YSI model 2300
dual analyzer (Yellow Springs Instrument Co., Yellow Springs,
OH, U.S.A.). CSF concentrations of amino acids at baseline
and 4 hr after the induction of meningitis were measured by
HPLC (chromatograph HP 1090, Hewlett Packard, Santa
Clara, CA). 
The CSF samples were deproteinized with sulfosalicylic acid
and CSF amino acids were determined with a 451 Alpha Plus
amino acid analyzer (LKB Biochrome, Cambridge, U.K.). At
the end of the experiment, brain cortex was rapidly harvest-238 S.Y. Ko, J.W. Shim, S.S. Kim, et al.
ed using guillotine, frozen in liquid nitrogen, and stored at
80℃ for further biochemical analyses. 
Biochemical analyses of brain cortex
Methods of preparing brain cell membrane and determin-
ing cerebral cortical cell membrane Na
+, K
+-ATPase activity,
levels of conjugated dienes, tissue glucose and lactate concen-
trations, ATP and phosphocreatine (PCr) were described pre-
viously in detail (16-18). Briefly, brain cell membranes were
prepared according to the method described by Harik et al.
(19). The activity of cerebral cortical cell membrane Na
+, K
+-
ATPase was determined by subtracting the enzyme activity
in the presence of ouabain from the total activity in the ab-
sence of ouabain (20). The level of conjugated dienes was de-
termined by using the method of Recknagel and Glende (21).
The concentrations of glucose and lactate in the cerebral cor-
tex were determined spectrophotometrically by using a com-
mercially available kit (Sigma Diagnostics). Brain concentra-
tions of ATP and PCr were determined with a coupled en-
zyme assay, using the method of Lamprecht et al. (22). 
Statistical analysis 
Data were given as mean±standard error (SE). Data were
analyzed by unpaired t-test for intergroup comparisons. To
detect significant changes over time within each group, data
were compared by using repeated measures analysis. Statis-
tical analyses described above were done by using SPSS soft-
ware program version 10.0. A p-value of <0.05 was consid-
ered significant. 
RESULTS
Physiological variables
No significant differences in physiological values, such as
heart rate, arterial pH, PaO2, PaCO2 and base excess were ob-
served throughout the experiment between the three exper-
imental groups  (Table 1).  
In NC, there were no significant changes in ICP and mean
arterial blood pressure (MABP) (Fig. 1). In MC, ICP increased
progressively and became significantly different from corre-
sponding values in NC after 1 hr. Increased ICP in MC was
not attenuated in MK. In MC, at 3 hr of meningitis, MABP
was decreased but soon recovered to normal value. In MK,
MABP was transiently but significantly increased until 1 hr
after the MK-801 injection, and after then returned to nor-
mal values. Cerebral perfusion pressure (CPP), calculated as
MABP minus ICP, was transiently increased in MK, imme-
diately after the MK-801 injection for 1 hr, and  significantly
decreased after 2 hr in both MC and MK. 
Glucose and Lactate concentrations in the blood, brain,
and CSF
There were no significant differences in blood and brain gl-
ucose and lactate levels between three experimental groups
(Table 1, 2). In MC, CSF glucose level significantly decreased
after 3 hr, lactate level significantly increased after 1 hr of
meningitis, and these abnormalities were not significantly
attenuated in MK (Table 2).
Glutamate concentration, bacterial titer, leukocyte
counts and TNF- levels in CSF
Glutamate concentration in the CSF at baseline was not
significantly different between the three experimental groups,
and the elevated concentration observed in MC compared to
Glucose (mmol/kg) 3.84±0.32 3.61±0.23 3.76±0.31
Lactate (mmol/kg) 3.36±0.37 4.14±0.49 3.93±0.18
Na+, K+-ATPase
( molPi/mg protein/hr) 53.60±0.99 47.34±0.77 48.83±0.46*
Conjugated dienes
( mol/g protein) 0.82±0.02 1.05±0.03* 0.94±0.02*
�
ATP (mmol/kg) 3.53±0.26 3.08±0.18 3.96±0.08*
�
Phosphocreatine 
(mmol/kg) 3.83±0.28 2.82±0.21* 3.94±0.15
�
Table 2. Biochemical data in the cerebral cortex of newborn
piglets in each experimental group
NC (n=9) MC (n=21) MK (n=14)
NC, Normal control group; MC, Meningitis control group; MK, meningi-
tis with MK-801 pretreatment group.
Values given represent mean±SE. * : p<0.05 compared to NC. 
�: p<0.05 compared to MC
Heart Rate (beats/min) 204±12 186±7 179±9
Arterial base 
excess (mEq/L) 2.31±1.04 -1.51±1.29 -1.38±0.89
Arterial pH 7.47±0.05 7.38±0.02   7.38±0.02
Blood glucose 
(mg/dL) 95.8±19.1 75.7±6.4 89.3±5.4 
CSF glucose 
(mg/dL) 64.2±5.5 32.9±6.9* 39.6±4.4*
Blood lactate 
(mmol/L) 1.3±0.2 1.5±0.2 1.4±0.1
CSF lactate 
(mmol/L) 2.5±0.3 6.9±0.5* 7.5±0.4*
Bacterial titer 
(*10
5 cfu/mL) 0 2.9±0.6* 2.8±0.4*
Glutamate in CSF 
(nmol/L) 36.2±10.2 123.5±29.2* 93.3±21.1*
Table 1. Physiological data at 4 hr of experiment in each group
of newborn piglets
NC (n=9) MC (n=21) MK (n=14)
NC, Normal control group; MC, Meningitis control group; MK, meningi-
tis with MK-801 pretreatment group.
Values given represent mean±SE. * : p< 0.05 compared to NC.MK-801 in Neonatal Meningitis 239
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Fig. 2. Changes in tumor necrosis factor-alpha (TNF- ) and leukocyte counts in the CSF of newborn piglets in each experimental group
with time. NC, Normal control group; MC, Meningitis control group; MK, meningitis with MK-801 pretreatment group.
Data are expressed as mean±SE; * : p<0.05 compared to NC; # : p<0.05 compared to MC.
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Fig. 1. Time course of intracranial pressure, mean arterial pressure
and cerebral perfusion pressure in newborn piglets in each ex-
perimental group. NC, Normal control group; MC, Meningitis
control group; MK, meningitis with MK-801 pretreatment group.
Data are expressed as mean±SE; * : p<0.05 compared to NC;
# : p<0.05 compared to MC.
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NC at 4 hr after the bacterial inoculation was not significantly
attenuated in MK (Table 1). The bacterial titer in the CSF
between MC and MK was not significantly different through-
out the experiment (Table 1). Leukocyte counts and TNF-
levels in the CSF were significantly elevated at 2 hr and 4
hr in MC, compared to NC (p=0.000, 0.022) and these ele-
vations were not significantly attenuated in MK (Fig. 2).
Biochemical data in cerebral cortex
Levels of lipid peroxidation products (conjugated dienes),
measured as an indicator of alterations in cell membrane struc-
ture, were significantly elevated in MC compared to NC, and
this elevation was significantly attenuated in MK (Table 2).
Cerebral cortical cell membrane Na
+, K
+-ATPase activity, me-
asured as an index of brain cell membrane function, decreased
significantly in MC compared to NC, and this abnormality
was not significantly improved in MK. Cerebral ATP levels
were not significantly reduced, but PCr was significantly re-
duced in MC compared to NC (p=0.015), and the concentra-
tions of ATP and PCr were significantly increased in MK
(p<0.01). 240 S.Y. Ko, J.W. Shim, S.S. Kim, et al.
DISCUSSION
In the present study, although it failed to down-modulate
the inflammatory parameters such as increased ICP, CSF
leukocytosis, increased lactate and TNF- levels in the CSF,
and hypoglycorrhachia observed in the meningitis group,
MK-801 pretreatment showed some neuroprotective effects
as evidenced by significant attenuation of cerebral lipid per-
oxidation products (conjugated dienes) and increase of brain
high-energy phosphate compounds (ATP and PCr). The
failure of MK-801 pretreatment to attenuate the acute inflam-
mation suggest that the role of excitotoxicity in mediating
the acute inflammatory responses may not be essential, at
least during the early phase of neonatal bacterial meningitis.
Leib et al. reported the neuroprotective effect of an excitatory
amino acid antagonist, kynurenic acid (12). They showed
protective effect from excitotoxic neuronal injury through
the inhibition of EAA receptors in experimental bacterial
meningitis. Reduction of brain edema resulting from EAA
inhibition may have more beneficial effects indirectly by
reducing intracranial pressure and by improving cerebral
blood flow. Neuroprotective effects observed with MK-801
pretreatment in this study and with kynurenic acid in a rat
model of group B streptococcal meningitis suggest an impor-
tant contribution of excitotoxicity to neuronal injury in these
animal models of neonatal bacterial meningitis. 
Accumulation of cytosolic calcium by the activation of
glutamate receptors induces various deleterious events, includ-
ing especially the generation of oxygen free radicals (23).
Oxygen free radicals attack double bonds of polyunsaturated
fatty acids in cell membranes in the process called lipid per-
oxidation, and induce cell injury by altering cell membrane
structure and fluidity (24, 25). Therefore, our data of increased
lipid peroxidation products (conjugated dienes) observed in
MC indicate increased free radical production and the resul-
tant oxidant-induced brain cell membrane injury during
bacterial meningitis. Significant attenuation of these abnor-
malities observed with MK-801 pretreatment in this study
support the assumption that oxygen free radicals play a criti-
cal role in mediating excitotoxicity-induced neuronal cell
death (24, 25). 
Oxygen free radicals could deplete cellular energy stores dir-
ectly by impairing mitochondrial oxidative metabolism (26),
or indirectly by activating poly (ADP-ribose) polymerase (27).
Therefore, our data of the significant reduction in cerebral
high energy phosphate compounds (ATP and PCr) observed
in the meningitis group and the significant improvement of
these abnormalities with MK-801 pretreatment could be ex-
plained by the impairment of mitochondrial oxidative meta-
bolism due to increased production of oxygen free radicals, key
mediators of excitotoxicty during bacterial meningitis and
significant attenuation of the production of oxygen free rad-
icals with MK-801 pretreatment. 
Degradation of cell membrane structure by lipid peroxi-
dation reduces Na
+, K
+-ATPase activity and results in brain
cell dysfunction that may lead to osmotic cell swelling and
neuronal death (28). Therefore, increased levels of lipid per-
oxidation products (conjugated dienes) might be primarily
responsible for the reduced Na
+, K
+-ATPase activity observed
in MC in this study. Since decreased Na
+, K
+-ATPase activ-
ity was observed for more than 30% reduction from baseline
in high-energy phosphate compounds, reduced Na
+, K
+-ATP
ase activity in MC could not be attributable to cerebral ener-
gy depletion. In MK, although increased levels of lipid per-
oxidation products (conjugated dienes) were significantly
attenuated, the improvement in reduced Na
+, K
+-ATPase
activity failed to reach a statistical significance. 
Excitotoxicity is based on the release of EAA, mainly glu-
tamate, and is an important concept to explain the pathophysi-
ology of brain ischemia (4, 5). Hypoxia-ischemia can disrupt
the function of excitatory synapses with depletion of energy
phosphate, leading to the accumulation of extracellular glu-
tamate, combined with opening of channels operated by glu-
tamate receptors. Excessive synaptic glutamate concentrations
result from both the excessive presynaptic release and the fail-
ure of reuptake, due to the energy failure of ion exchange sys-
tems and resultant membrane depolarization (29, 30). In bac-
terial meningitis, inflammation in subarachnoid space sur-
rounds blood vessels, and the resulting vasculitis causes tem-
porary vasospasm (31-33). Brain edema, increased ICP, sys-
temic hypotension, and impaired cerebral blood flow autoreg-
ulation can lead to a decrease in cerebral blood flow (34). These
changes result in local ischemic damage with subsequent glu-
tamate release and development of excitotoxic injury like hy-
poxic ischemic encephalopathy. However, our data of signif-
icant increase in gluamate concentration without systemic
hypotension in MC, and the failure of significant attenua-
tion of these abnormalities despite significant improvement
in cerebral energy stores in MK suggest that excitotoxicity
can occur without global ischemia and widespread depletion
in cerebral energy stores during the early phase of bacterial
meningitis. Energy depletion at the cellular level due to acute
inflammatory responses and anaerobic glycolysis might be
responsible for these abnormalities. Further studies will be
necessary to clarify this. Transient but significant increase in
MABP observed with MK-801 pretreatment could be explain-
ed by its sympathetic nervous system stimulatory effects (35).
However, whether this effect is related to some neuroprotec-
tive effects of MK-801 is not clear. 
In summary, our results sugest that MK-801 pretreatment
may have some neuroprotective effects in experimental neona-
tal bacterial meningitis although it failed to attenuate the acute
inflammatory responses. 
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